Physician profile
Steven Max Rapp
NPI 1073589446
$21,578.90
in general payments reported to CMS, 2019-2025
39 companies · $1,844 in 2025
The $1,844 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,614 · 2020: $1,946 · 2021: $4,294 · 2022: $5,951 · 2023: $1,783 · 2024: $4,146 · 2025: $1,844.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,561 · Travel and Lodging: $2,213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,561.19 |
| Travel and Lodging | $2,212.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovasis INC | $9,414.96 | 2021-2024 | |
| Spineology INC. | $2,657.56 | 2022-2025 | Optimesh Expandable Interbody Fusion System |
| Medtronic, INC. | $1,872.70 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Osteocool Rf Ablation System |
| Spine Wave, INC. | $1,689.46 | 2019-2021 | |
| Spinal Elements, INC. | $936.53 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $615.33 | 2020-2021 | |
| Medtronic USA, INC. | $473.36 | 2019-2020 | |
| Saluda Medical Americas, INC. | $450.44 | 2023-2025 | Evoke, Evoke Scs |
| Surgentec | $429.40 | 2020 | |
| Intrinsic Therapeutics | $381.20 | 2022-2024 | Barricaid Acd (Annular Closure Device) |
| Orthofix Medical, INC. | $275.05 | 2020-2021 | |
| Si-Bone, INC. | $245.09 | 2021-2024 | |
| Baxter Healthcare | $205.85 | 2019-2023 | Floseal |
| Abbvie INC. | $161.54 | 2023-2025 | |
| Depuy Synthes Sales INC. | $129.44 | 2024 | Spine & Trauma 3d Navigation, Teligen |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $127.80 | 2023-2025 | Xeomin |
| Vertiflex, INC. | $121.27 | 2019 | |
| Icotec Medical INC. | $118.19 | 2024 | Vader Pedicle System |
| Lifenet Health | $116.68 | 2024 | Allograft Vmis Delivery System |
| Augmedics INC. | $116.29 | 2024 | Xvision |
| Nevro Corp. | $115.81 | 2020-2024 | Senza |
| Aesculap, INC. | $113.64 | 2022-2024 | M.Blue |
| Elevation Spine, INC. | $104.58 | 2024 | |
| Livanova USA, INC. | $102.01 | 2024-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Centinel Spine, LLC | $101.91 | 2021 | |
| Boston Scientific Corporation | $86.63 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Camber Spine Technologies LLC | $73.11 | 2020 | |
| Globus Medical, INC. | $66.40 | 2025 | Senza |
| Pacira Pharmaceuticals Incorporated | $48.54 | 2023-2025 | Exparel |
| Medacta USA, INC. | $38.94 | 2024 | |
| Stryker Corporation | $28.38 | 2020 | |
| Alphatec Spine, INC | $27.10 | 2022 | |
| Mimedx Group, INC. | $26.72 | 2024 | |
| Scilex Pharmaceuticals INC. | $22.39 | 2023 | Ztlido |
| Smith+Nephew, INC. | $20.56 | 2025 | Grafix Pl |
| Lilly USA, LLC | $19.69 | 2025 | Zepbound, Mounjaro |
| Otsuka America Pharmaceutical, INC. | $17.51 | 2024 | Nuedexta |
| Allergan, INC. | $15.32 | 2021 | |
| Strongbridge US INC. | $11.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Rapp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.